13.07.2020 at 22:02:51    

 Welcome, Guest. Please Login.
Pages: 1
2001 (Read 4915 times)
Group Leader

Posts: 37
Gender: male
20.03.2007 at 12:43:23
19.      Pumpens P., Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology, 44(2-3): 98-114, 2001.  
20.      Lazdina U., Cao T., Steinbergs J., Alheim M., Pumpens P., Peterson D.L., Milich DR, Leroux-Roels G, Sallberg M. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J. Virol, 75: 6367-6374, 2001.
21.      Pumpens P., Grens E. [Vaccines and other immunobiological tools today and tomorrow]. Latvijas Ārsts, N 10. 28-32, 2001.  
22.      Dumpis U., Edward C., Holmes E., Mendy M.  ,  Hill A., Thursz M., Hall A., Whittle H., Karayiannis P. Transmission of hepatitis B virus infection in Gambian families revealed by phylogenetic analysis. Journal of Hepatology. 35, 99-104, 2001.
23.      Dumpis U., Mendy M., Hill A.V., Thursz M., Hall A., Whittle H., Karayiannis P. Prevalence of HBV core/promoter/core mutations in Gambian chronic carriers.   Journal of Medical Virology 65; 4: 664-670, 2001.
24.      Kalnina A., Gabruševa N., Brūvere R. , Zvagule T, Heisele O., Volrāte Ā., Feldmane G., Meirovics I.. Phenotypical characteristics of leukocyte membranes in Chernobyl clean-up workers from Latvia: use of the fluerescent probe ABM. Proc. Latvian Acad. of Sciences, v.55, Nr 1, 6-14, 2001.
25.      Heisele O., Ferdats A., Engele L, Rupais A. Clinical value of melanoma associated antigens. J.Tumor Marker Oncology, 2001, v.16, Nr 2, p.106.
26.      Kurjane N., Bruvere R., Shitova O., Romanova T., Jaunalksne I., Kirschfink M., Sochnev A. Analysis of the Immune Status in Latvian Chernobyl Clean-up Workers With Non-Oncological Thyroid Diseases. Scandinavian J. Immunology, , vol 54, 528-533, 2001.
27.      Mironova-Ulmane N., Pavlenko A., Zvagule T., Karner T., Bruvere R., Volrate A. Retrospective Dosimetry for Chernobyl Workers in Latvia. – Radiation Protection Dosimetry, vol. 96, 237-240, 2001.
28.      Erenpreisa Je.,Cragg M.S. Mitotic death: A mechanism of survival? A review. Cancer Cell International 1:1 (online: www.cancerci.com), 2001.
29.      Erenpreiss Ju., Bars J., Lipatnikova J., Erenpreisa Je., Zalkalns J. Comparative study of cytochemical tests for sperm chromatin integrity. Journal of Andrology (USA), 22: 45-53, 2001.
30.      Ivanovs A.,Erenpreisa Je. [Changes of mitotic regime in the malignant tumours]. ‘Jums kolegi’, 2: 34-39 (in Latvian), 2001.  
31.      Erenpreisa Je., Ivanov A. Review: Endopolyploidy in development and cancer: A possible relation to genotoxic resistance of malignant tumours. Vestis LZA, Ser.B, 2001.
32.      Erenpreiss Ju., Hlevicka S., Zalkalns J.,  Erenpreisa Je. Impact of leukocytospermia on sperm DNA integrity: Dramatic effect in infertile men. J. Andrology (USA), 2001.
33.      Baumanis V., Kalnina V., Jansone I., Bormane A., Marga O., Pančuka T., Pole I. Molecular typing of bacterial infections in Latvia, The European Journal of Biochemistry, v.268, S1,  48, 2001.
34.      Pole I.  Jansone I., Broka L., Puzuka A., Panchuka T. , Marga O., Baumanis V. Molecular epidemiology of tuberculosis in Latvia. The International Journal of Tuberculosis and Lung disease, Vol.5, Nr.11, 140-141, 2001.
35.      Baumanis V., Kalnina V., Jansone J., Bormane A., Ranka R. Marga O., Pole I., Panchuka T. Molecular typing of bacterial infections in Latvia. European Journal of Biochemistry, v.268, s.1, 48, 2001,  
36.      Baumanis V., Kloviņš J., Ranka R., Vetcmane-Vetce K., Puzuka A., Lavrinoviča M., Bormane A., Kalniņa V. Incidence of Borrelia Burgdorferi infected ticks in Latvia and their molecular typing. Proceedings of the Latvian Academy of Sciences, v.55, 164-170, 2001.
37.      Panchuka T., Baumanis V., Jansone I., Broka L., Marga O. Evaluation of gene mutations leading to drug resistance of Mycobacterium tuberculosis in Latvia.Submitted to Journal of Clinical Microbiology, 2001.  
38.      Krūmiņa A., Kroškina V., Keišs J.,  Mališeva B., Baumanis V. Ar hereditāro hemohromatozi saistītā gēna HFE mutācijas Latvijas poplulācijā.LMA Zinātniskie raksti, Rīga, AML/RSU, 134-138, 2001
39.      Pumpens P., Baumanis V. [Gene therapy, what it is] .Latvijas Ārsts, Nr.1, 37-40, 2001,  
40.      Baumanis V., Pumpens P. [Gene therapy, real success] .Latvijas ārsts, Nr.3, 40-43, 2001.
42.      Liepinsh E., Baryshev M., Sharipo A., Ingelman-Sundberg M, Otting G and Mkrtchian S. Thioredoxin fold as homodimerization module in the putative chaperone ERp29: NMRstructures of the domains and experimental model of the 51 kDa dimer. Structure (Camb).;9(6):457-471,2001 Jun.
43.      Sharipo A., Imreh M., Leonchiks A., Branden C., Masucci M.G. cis-Inhibition    of proteasomal degradation by viral repeats: impact of length and amino acid composition. FEBS Lett. 15;499 (1-2):137-142, 2001Jun.
44.      Tihomirova L., Sinicka O., Smite D., Stengrevics A., Recurrent mutations of BRCAI gene as diagnostic genetic markers of hereditary breast cancer in Latvian Pacients. J. of tumor marker Oncology, vol 16. Nr.2, 2001.
45.      T. Zvagule, N. Mironova-Ulmane, A. Pavlenko, T. Karner, R.Bruvere, N.Gabruševa, A. Volrate. Retrospective dosimetry and clinical follow-up program for Chernobyl clean-up workers in Latvia. Proceedings of the IRPA regional congress on radiation protection in Central Europe Dubrovnik, Croatia, May 20-25, 2001 (ISBN 953-96133-3-7)  
46.      A.Leice, R. Bruvere, N. Gabruševa, V. Balodis. Evaluation of Chernobyl Accident Late Health Effects by Hematological and Clinical Biochemistry tests. Acta Universitatis Latviensis. Medicine.2001, vol 643, 77-84.  
Back to top
View Profile   IP Logged
Pages: 1